GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **801 - 825** of **4050** in total

« First

‹ Prev

…

29

30

31

32

33

34

35

36

37

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▲	Arbitrary Fluorescence Units (AFU)
IgG	Patient 3	-180	mild	G16579HJ	58
IgG	Patient 3	11	mild	G16579HJ	148
IgM	Patient 3	-180	mild	G16579HJ	171
IgA	Patient 3	4	mild	G16579HJ	717
IgG	Patient 3	4	mild	G16579HJ	156
IgM	Patient 3	11	mild	G16579HJ	1272
IgM	Patient 3	4	mild	G16579HJ	1433
IgA	Patient 4	12	mild	G16579HJ	663
IgG	Patient 4	12	mild	G16579HJ	134
IgM	Patient 4	12	mild	G16579HJ	612
IgA	Patient 1	10	moderate	G17140UR	423
IgA	Patient 1	22	moderate	G17140UR	578
IgA	Patient 1	6	moderate	G17140UR	282
IgG	Patient 1	10	moderate	G17140UR	27
IgG	Patient 1	22	moderate	G17140UR	67
IgG	Patient 1	6	moderate	G17140UR	26
IgM	Patient 1	10	moderate	G17140UR	72
IgM	Patient 1	22	moderate	G17140UR	637
IgA	Patient 2	15	mild	G17140UR	590
IgA	Patient 2	24	mild	G17140UR	634
IgG	Patient 2	15	mild	G17140UR	91
IgG	Patient 2	24	mild	G17140UR	91
IgM	Patient 2	15	mild	G17140UR	806
IgM	Patient 2	24	mild	G17140UR	806
IgM	Patient 1	6	moderate	G17140UR	66